| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |